Dimensional Fund Advisors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Dimensional Fund Advisors’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,626	Closed	-$421K	–	3407
2024 Q3	$421K	Sell	12,626 -1,115	-8%	-$38.4K	﹤0.01%	3066
2024 Q2	$371K	Sell	13,741 -6,233	-31%	-$123K	﹤0.01%	3073
2024 Q1	$431K	Sell	19,974 -12,773	-39%	-$279K	﹤0.01%	3071
2023 Q4	$198K	Buy	32,747 +20,359	+164%	+$101K	﹤0.01%	3198
2023 Q3	$68.7K	Buy	+12,388	New	+$79.8K	﹤0.01%	3354

Dimensional Fund Advisors's LBPH Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 12,626 shares — an estimated $421K sold.

Dimensional Fund Advisors first reported a position in LBPH in Q3 2023 and held it in 5 quarters. The position peaked at $431K in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Dimensional Fund Advisors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Dimensional Fund Advisors sold 12,626 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $421K.
Dimensional Fund Advisors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
Dimensional Fund Advisors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $431K in Q1 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.